Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Jupiter Neurosciences, Inc. (JUNS), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
-0.14
P/B ratioShare price divided by book value per share.
-4.24
P/S ratioMarket value divided by annual revenue.
56.66
PEG ratioP/E divided by the earnings growth rate.
0.00
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
-0.42
EV / RevenueEnterprise value against annual revenue.
60.17
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
-588.24%
Free cash flow yieldFree cash flow as a percentage of market value.
-197.78%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
88.34%
Operating marginRevenue left after operating costs.
-230.76%
Net marginRevenue left after every cost, including tax and interest.
-226.91%
Return on equityProfit as a percentage of shareholders’ equity.
747.33%
Return on assetsProfit as a percentage of total assets.
-247.39%
Return on capital employedOperating profit against the capital the business uses.
900.00%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
0.66
Quick ratioThe same, excluding inventory.
0.62
Cash ratioCash alone against current liabilities.
0.57
Debt to equityTotal borrowings against shareholders’ equity.
-4.78
Debt to assetsTotal borrowings against total assets.
0.83
Interest coverageHow many times operating profit covers the interest bill.
-47.42
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$-18.75
Shares outstandingShares currently issued.
0
Market capitalisationShare price times shares outstanding.
$3.93M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$3.67M
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
0.00%
Jupiter Neurosciences, Inc. (JUNS) statistics — frequently asked questions
What is Jupiter Neurosciences, Inc.'s P/E ratio?
Jupiter Neurosciences, Inc. (JUNS) trades on a price-to-earnings ratio of -0.14. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.
What is Jupiter Neurosciences, Inc.'s return on equity?
Jupiter Neurosciences, Inc. (JUNS) reports a return on equity of 747.33%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Jupiter Neurosciences, Inc. carry?
Jupiter Neurosciences, Inc. (JUNS) has a debt-to-equity ratio of -4.78, which compares total borrowings with shareholders' equity.
What is Jupiter Neurosciences, Inc.'s profit margin?
Jupiter Neurosciences, Inc. (JUNS) keeps -226.91% of revenue as net profit after every cost, including tax and interest.